Form 4: OptimizeRx Corp Executive Reports Stock Transactions
SEC Form 4 Filing
Marion Odence-Ford, Chief Legal Officer & CHRO of OptimizeRx Corp, reports the vesting and subsequent tax withholding of restricted stock units.
Summary
- On March 1, 2025, Marion Odence-Ford, Chief Legal Officer & CHRO of OptimizeRx Corp, had 771 restricted stock units vest.
- These units convert into common stock.
- Also on March 1, 2025, 268 shares of common stock were withheld by OptimizeRx Corp to satisfy tax obligations related to the vesting of the restricted stock units at a price of $5.18.
- Following these transactions, Odence-Ford directly owns 70,276 shares of OptimizeRx Corp common stock.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by an executive, with no inherent positive or negative implications for the company's performance.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their stock transactions. It's a standard practice for executives to receive and vest stock options or restricted stock units as part of their compensation, and subsequent sales or tax withholdings are regularly reported.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they involve a small number of shares relative to the total outstanding.
Key Dates
| Date | Description |
|---|---|
| 03/01/2023 | First anniversary of the grant date of the restricted stock units, marking the beginning of vesting in three equal annual installments. |
| 03/01/2025 | Date of transaction: vesting of 771 restricted stock units and withholding of 268 shares for tax obligations. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.